WO2019132536A1 - 생분해성 물질을 포함하는 팽창 속도가 제어된 치과용 기구 및 이의 제조 방법 - Google Patents
생분해성 물질을 포함하는 팽창 속도가 제어된 치과용 기구 및 이의 제조 방법 Download PDFInfo
- Publication number
- WO2019132536A1 WO2019132536A1 PCT/KR2018/016743 KR2018016743W WO2019132536A1 WO 2019132536 A1 WO2019132536 A1 WO 2019132536A1 KR 2018016743 W KR2018016743 W KR 2018016743W WO 2019132536 A1 WO2019132536 A1 WO 2019132536A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- hydrogel
- pores
- holes
- biodegradable sheet
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0003—Not used, see subgroups
- A61C8/0004—Consolidating natural teeth
- A61C8/0006—Periodontal tissue or bone regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/02—Devices for expanding tissue, e.g. skin tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
Definitions
- the present invention relates to a gingival expander including a biodegradable material and controlling the rate of expansion of a hydrogel, and a method of manufacturing the same. More particularly, the present invention relates to a gingival expander that controls the size and number of pores or holes A biodegradable polymer sheet is formed in the pores or holes to keep the gingival expander from being inflated during the healing period of the incision site of the surgery so that a sufficient healing time can be secured, The present invention relates to a gingival expander in which a swelling rate can be controlled by inflow of a body fluid through an opened pore or hole after the polymer sheet is completely healed, thereby expanding the hydrogel.
- GBR guided bone regeneration augmentation
- This bone induction regeneration regenerates the bone tissue by forming a space using a barrier at the edentulous region regardless of the periodontal tissue and inducing osteoblast flow into the bone defect portion under the space,
- absorbent, nonabsorbable dental shields and various bone materials are used.
- the dental barrier prevents the gingival epithelium that is early to regenerate from reaching the injured part and prevents it from entering, and has a proper space maintenance ability, which helps to differentiate connective tissue and regenerate bone.
- techniques for dental restoration membranes that can improve the success rate of implant treatment by helping the prognosis of bone induction regeneration have been developed.
- the gingival expansion technique corresponds to a tissue expanding technique that secures the space necessary for alveolar bone regeneration by expanding the gingival recession using the self-expanding property of the hydrogel prior to the guided bone regeneration (GBR) procedure to the normal state before tooth loss.
- GBR guided bone regeneration
- a hydrogel that expands by absorbing body fluids is surrounded by a pore or a hole-formed silicon film, and absorbs the body fluids to expand.
- the size or number of pores or holes formed in the silicon film The rate of expansion of the hydrogel is controlled by controlling the amount of body fluid being introduced.
- Patent Document 0001 Patent Registration No. KR 10-1668679
- Patent Document 0002 Registered Utility Model No. KR 20-0475611
- the present invention relates to a gingival expander which absorbs body fluids and is surrounded by pores or perforated silicone membranes that absorb and expand body fluids, and the amount of body fluids flowing into the pores or holes formed by the existing gingival expanders is controlled And to solve the problems and limitations by controlling the expansion rate.
- a biodegradable sheet capable of shielding the pores or holes is formed on the surface of a silicon shell including pores or holes into which saliva or liquid can flow, while enclosing the hydrogel in a gingival expander
- a gingival expander with controlled expansion rate includes: a hydrogel for absorbing body fluids and swelling to secure a space in the gingiva; And a silicone shell surrounding the hydrogel and including pores or holes into which saliva or fluid may enter, wherein the biodegradable sheet is positioned on the surface of the silicon shell to shield the pores or holes .
- the biodegradable sheet is a natural polymer selected from the group consisting of chitosan, choline, hyaluronic acid, collagen, alginic acid, heparin, starch, xanthan, lignin, cellulose, curdlan, fibrinogen, gelatin, ; Or copolymers of lactic acid and glycolic acid, polyglycolic acid, polyethylene glycol, polycaprolactone, polyautoester, polyphosphazene, polydecavacin, polyhydroxybutyric acid, And a synthetic polymer selected from the group consisting of a copolymer of hydroxybutyric acid and hydroxyvaleric acid and a polyester of succinic acid.
- the hydrated gel is preferably a hydrated gel in which a monomer having methacrylate and a monomer having vinyl group are crosslinked.
- the hydrated gel is preferably a triangular, square, Or an elliptical columnar shape.
- the saliva or the sap flows through the pores or holes into the inside of the silicone shell, and the carboxyl group on the surface of the hydrogel is ionized, .
- Another embodiment of the present invention is a method of manufacturing a gingival expander, comprising: a first step of polymerizing a hydrogel; A second step of modifying the methylene chain of the methacrylate of the hydrated gel into a carboxyl group by subjecting the polymerized hydrated gel to an alkaline treatment; A third step of compressively drying the hydrolyzed gel treated with the alkali agent using a drying mold; A fourth step of placing the compressively dried hydrated gel in a silicon shell having pores or holes through which saliva or liquid can flow into the interior and then joining the ends of the silicon shell using an adhesive; And a fifth step of attaching the biodegradable sheet to shield pores or holes formed in the surface of the silicon shell.
- the biodegradable sheet is thermally bonded to the surface of the silicon shell.
- a gingival dilator with controlled expansion rate is a gingival dilator which surrounds a hydrogel in a gingiva expander and is configured to shield the pores or holes on the surface of a silicon shell including pores or holes into which saliva or liquid can flow,
- a biodegradable sheet can be placed so that the gingival expander can be given a time sufficient for the tissue to be cured in a state in which the gingival expander is not inflated during the initial period after the operation and can be expanded after the tissue is completely healed, The procedure can be performed in a state where the tissue is sufficiently healed and stabilized, and the effect of having a high procedure success rate is obtained.
- Fig. 1 is a photograph (a) of a gingival expander according to the present invention and Fig. 1 (b) is a schematic diagram showing a specific structure thereof.
- FIG. 2 is a result of measuring the decomposition rate of the biodegradable sheet according to an embodiment of the present invention.
- FIG. 3 shows the results of measurement of changes in expansion volume with time of the hydrogel according to the sample / control of the biodegradable sheet according to the present invention.
- FIG. 1 (a) shows a gingival expander with an inflation rate controlled according to an embodiment of the present invention
- FIG. 1 (b) schematically shows a specific form.
- the gingiva expander according to the present invention shown in FIG. 1 includes a hydrogel 100 capable of swelling by absorbing body fluids and the hydrogel 100, and has a pore or hole through which the saliva or liquid can flow into the inside, (200), wherein the biodegradable sheet (400) is positioned on the surface of the silicon shell (200) to shield the pores or holes.
- the joining portion 500 may be formed on both sides or at least one side of the silicone shell 200 so as to surround the hydrogel 10.
- the joining portion 500 of the silicone shell and the screw As shown in FIG.
- a screw is used on both side joints 500 of the silicone shell 200, there is an advantage that it is perfectly fixed to the alveolar bone and movement in the gingival is prevented.
- the hydrogel absorbs body fluid to secure a space in the gingiva through swelling in the body.
- the hydrogel contains a monomer having a methacrylate group and a monomer having a vinyl group Crosslinked polymers may be used.
- MMA methyl methacrylate
- VP vinyl-pyrrolidone
- HEMA vinyl-pyrrolidone
- VP vinyl-pyrrolidone
- the -COOH functional groups of the methacrylate (methacrylate) that comprise the hydrogels 100 -COO - and is dissociated into H + -COO - cross hydrogel polymer resulting from The repulsive force of the liver is increased, which causes the gap between the polymer chains to become self-swelling capability.
- the swollen hydrogel 100 is swollen in a round cylinder shape that allows the gingiva to swell broadly regardless of its initial shape.
- the hydrogel of the gingival expander is dried under various pressure conditions using various types of drying molds for the convenience of the procedure, so that the shape of the hydrogel can be controlled.
- a polygonal column can be used. It is more preferable that the cross section of the multi-stranded hydrogel is a regular polygon having 3 to 8 sides and the contact area of the hydrated gel with the alveolar bone is 0.35 to 1.5 cm 2 .
- the hydrogel may be of a streamlined type.
- the streamlined hydrogel is preferably a flat streamlined type having a narrower width toward one side or both sides. Such a streamlined hydrogel may be easily inserted into the gingiva Because of its flat shape, the area of contact with the alveolar bone is widened during the procedure, and it is placed in the gingiva, which increases the convenience of the procedure.
- the silicon shell 200 is a perforated or semipermeable membrane, and holes (pores or holes) are formed so that body fluids or liquids can permeate.
- holes pores or holes
- the presence or absence and the number of holes of the silicone shell 200 Has controlled the rate of diffusion of body fluids inside the gingival expander.
- the biodegradable sheet 400 capable of shielding the pores or holes 300 formed on the surface of the silicone shell 200, the flow of body fluid after the implantation of the gingival expander is blocked,
- the biodegradable sheet 400 is decomposed to a predetermined level or higher, and the bodily fluids are introduced through the pores or holes 300 to control the time point at which the gingival expander expands.
- biodegradable sheet 400 it is preferable to use a natural polymer or a synthetic polymer harmless to the human body, and specifically, chitosan, chylin, , Fibrinogen, gelatin, fluoran, and polyamino acid; Or copolymers of lactic acid and glycolic acid, polyglycolic acid, polyethylene glycol, polycaprolactone, polyautoester, polyphosphazene, polydecavacin, polyhydroxybutyric acid, And a synthetic polymer selected from the group consisting of a copolymer of hydroxybutyric acid and hydroxyvaleric acid and a polyester of succinic acid.
- the decomposition time of the biodegradable sheet 400 to be used at this time can be controlled through the molecular weight of the biodegradable material or the thickness of the sheet.
- the body fluid is absorbed into the hydrogel through the pores or holes 300, I.e., the time point at which the hydrogel begins to expand.
- the biodegradable sheet 400 may be manufactured in the form of a patch having a biodegradable material formed thereon, and may be thermo-compressed and fixed in a region where pores or holes are formed in the silicon shell.
- the biodegradable sheet produced in the form of a patch is a sheet made of a polymer material such as polystyrene (PS), polyvinyl chloride (PVC), polymethyl methacrylate (PMMA), polyethylene terephthalate (PET) Or by forming a biodegradable material such as a natural polymer or a synthetic polymer harmless to the human body on the surface by spray coating or dip coating method.
- a polymer material such as polystyrene (PS), polyvinyl chloride (PVC), polymethyl methacrylate (PMMA), polyethylene terephthalate (PET)
- PS polystyrene
- PVC polyvinyl chloride
- PMMA polymethyl methacrylate
- PET polyethylene terephthalate
- the biodegradable material formed on the surface of the biodegradable sheet 400 has a function of shielding the pores or holes of the silicon shell for a certain period of time in the body and then losing the shielding function from about 70% .
- MMA vinyl-pyrrolidone
- VP 2-vinylpyrrolidone
- MMA crosslinked methyl methacrylate
- polymerization initiator polymerization initiator
- crosslinking agent hydroxypropyl methacrylate
- solvent methylpyrrolidone
- the methylene chain of the methacrylate of the hydrated gel was reformed into a carboxyl group by alkali treatment using the alkaline agent NaOH, and the resulting polymerized hydrogel was compressed and dried using a drying mold.
- the compressed and dried hydrated gel was placed inside a silicon shell having a hole with a diameter of 0.5 mm so that the saliva or the solution could flow into the inside, and then the end was bonded.
- the biodegradable sheet is thermocompression bonded at a temperature of about 85 degrees so as to block holes formed in the surface of the silicon shell.
- the biodegradable sheet preferably has a weight average molecular weight of 50,000 to 10,000, PLGA of 80,151 was used, which was extruded to a thickness of 1 mm and then cut into sheets.
- the biodegradation rate of the biodegradable sheet prepared in Example 1 was confirmed by loading the biodegradable sheet in PBS (Phosphate Buffered Saline, pH 7.0-7.4) solution, stirring at about 200 rpm at 37 ° C, And the weight was measured with elapsed time.
- PBS Phosphate Buffered Saline, pH 7.0-7.4
- FIG. 3 shows the results of measuring the expansion volume over time of a gingival dilator (sample) according to the present invention to which the biodegradable sheet of FIG. 2 was applied and a gingiva control without biodegradable sheet applied The size and number of holes formed are kept the same).
- the biodegradation rate was confirmed by changing the molecular weight of PLGA, a biodegradable polymer used in the production of biodegradable films.
- the concrete manufacturing process and the experiment of measuring the biodegradation rate are the same as in the first embodiment, and the results are summarized in FIG.
- the biodegradation rate of the biodegradable film was changed by controlling the molecular weight of the biodegradable film, which means that the expansion time of the gingival expander can be effectively controlled.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Developmental Biology & Embryology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dentistry (AREA)
- Dermatology (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (8)
- 체액을 흡수하여 팽윤됨으로써, 치은 내 공간을 확보하는 수화젤; 및상기 수화젤을 둘러싸고, 타액 또는 수액이 내부로 유입될 수 있는 기공 또는 구멍을 포함하는, 실리콘 쉘;을 포함하고,상기 실리콘 쉘의 표면에 상기 기공 또는 구멍을 차폐하도록 생분해성 시트가 위치하는 것을 특징으로 하는, 팽창 속도가 제어된 치은 확장기.
- 제1항에 있어서,상기 생분해성 시트는,키토산, 키린, 히알루론산, 콜라겐, 알긴산, 헤파린, 전분, 잔탄, 리그닌,셀룰로오스, 커들란, 피브리노겐, 젤라틴, 플루란 및 폴리아미노산으로 이루어진 군에서 선택되는 어느 하나의 천연고분자; 또는폴리락트산, 폴리락트산의 스테레로코폴리머, 락트산과 글리콜산의 공중합체, 폴리글리콜산, 폴리에틸렌글라이콜, 폴리카프로락톤, 폴리오토에스테르, 폴리포스파젠, 폴리덱사존, 폴리하이드록시부티르산, 하이드록시부티르산과 하이드록시발레르산의 공중합체 및 숙신산의 폴리에스테르로 이루어진 군에서 선택되는 어느 하나의 합성고분자;에서 선택되는 재질인 것을 특징으로 하는, 팽창 속도가 제어된 치은 확장기.
- 제1항에 있어서,상기 수화젤은, 메타크릴레이트(Methacrylate)를 갖는 모노머와 비닐(vinyl)그룹을 갖는 모노머가 가교결합된 수화젤인 것을 특징으로 하는, 팽창 속도가 제어된 치은 확장기.
- 제1항에 있어서,상기 수화젤은, 삼각기둥, 사각기둥 또는 오각기둥의 다각기둥형, 혹은 타원기둥형인 것을 특징으로 하는, 팽창 속도가 제어된 치은 확장기.
- 제1항에 있어서,상기 생분해성 시트가 분해됨에 따라, 기공 또는 구멍을 통해 타액 또는 수액이 실리콘 쉘의 내부로 유입되어, 상기 수화젤 표면의 카르복실기가 이온화되어 수화젤이 팽창하는 것을 특징으로 하는, 팽창 속도가 제어된 치은 확장기.
- 치은 확장기의 제조 방법에 있어서,수화젤을 중합하는 제1단계;중합된 수화젤을 알칼리제 처리함으로써, 수화젤의 메타크릴레이트의 메틸렌 체인을 카르복실기로 개질하는 제2단계;알칼리제 처리된 수화젤을 건조용 몰드를 사용하여 압축건조하는 제3단계;압축건조된 수화젤을, 타액 또는 수액이 내부로 유입될 수 있는 기공 또는 구멍이 형성된 실리콘 쉘 내에 위치시킨 후, 접착제를 사용하여 상기 실리콘 쉘의 끝 부분을 접합하는 제4단계; 및상기 실리콘 쉘의 표면에 형성된 기공 또는 구멍를 차폐하도록 생분해성 시트를 부착하는 제5단계;를 포함하는 팽창 속도가 제어된 치은 확장기의 제조 방법.
- 제6항에 있어서,상기 생분해성 시트는 실리콘 쉘의 표면에 열압착되어 부착되는 것을 특징으로 하는, 팽창 속도가 제어된 치은 확장기의 제조 방법.
- 제6항에 있어서,상기 생분해성 시트는,키토산, 키린, 히알루론산, 콜라겐, 알긴산, 헤파린, 전분, 잔탄, 리그닌, 셀룰로오스, 커들란, 피브리노겐, 젤라틴, 플루란 및 폴리아미노산으로 이루어진 군에서 선택되는 어느 하나의 천연고분자; 또는폴리락트산, 폴리락트산의 스테레로코폴리머, 락트산과 글리콜산의 공중합체, 폴리글리콜산, 폴리에틸렌글라이콜, 폴리카프로락톤, 폴리오토에스테르, 폴리포스파젠, 폴리덱사존, 폴리하이드록시부티르산, 하이드록시부티르산과 하이드록시발레르산의 공중합체 및 숙신산의 폴리에스테르로 이루어진 군에서 선택되는 어느 하나의 합성고분자;에서 선택되는 재질인 것을 특징으로 하는, 팽창 속도가 제어된 치은 확장기의 제조 방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170184141A KR20190081534A (ko) | 2017-12-29 | 2017-12-29 | 생분해성 물질을 포함하는 팽창 속도가 제어된 치과용 기구 및 이의 제조 방법 |
KR10-2017-0184141 | 2017-12-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019132536A1 true WO2019132536A1 (ko) | 2019-07-04 |
Family
ID=67063988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/016743 WO2019132536A1 (ko) | 2017-12-29 | 2018-12-27 | 생분해성 물질을 포함하는 팽창 속도가 제어된 치과용 기구 및 이의 제조 방법 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20190081534A (ko) |
WO (1) | WO2019132536A1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102338402B1 (ko) * | 2019-09-06 | 2021-12-13 | 오스템임플란트 주식회사 | 마이크로 버블을 포함하는 주입구를 가진 조직 확장기 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101446964B1 (ko) * | 2012-03-23 | 2014-10-07 | 오스템임플란트 주식회사 | 치주조직 재생기능이 탑재된 치은 확장기 |
KR200475611Y1 (ko) * | 2014-09-29 | 2014-12-16 | 오스템임플란트 주식회사 | 시술 편의성이 향상된 치과용 치은확장기 |
JP5800821B2 (ja) * | 2009-10-30 | 2015-10-28 | アイシス イノヴェイション リミテッド | 組織拡張器 |
KR101668679B1 (ko) * | 2014-05-30 | 2016-10-25 | 오스템임플란트 주식회사 | 시술 편의성이 높은 치과용 치은 확장기의 제조 방법 및 이러한 방법으로 제조된 치은 확장기 |
KR20170026330A (ko) * | 2014-04-14 | 2017-03-08 | 아키나, 인크. | 신규한 하이드로겔 조직 확장제 |
-
2017
- 2017-12-29 KR KR1020170184141A patent/KR20190081534A/ko not_active IP Right Cessation
-
2018
- 2018-12-27 WO PCT/KR2018/016743 patent/WO2019132536A1/ko active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5800821B2 (ja) * | 2009-10-30 | 2015-10-28 | アイシス イノヴェイション リミテッド | 組織拡張器 |
KR101446964B1 (ko) * | 2012-03-23 | 2014-10-07 | 오스템임플란트 주식회사 | 치주조직 재생기능이 탑재된 치은 확장기 |
KR20170026330A (ko) * | 2014-04-14 | 2017-03-08 | 아키나, 인크. | 신규한 하이드로겔 조직 확장제 |
KR101668679B1 (ko) * | 2014-05-30 | 2016-10-25 | 오스템임플란트 주식회사 | 시술 편의성이 높은 치과용 치은 확장기의 제조 방법 및 이러한 방법으로 제조된 치은 확장기 |
KR200475611Y1 (ko) * | 2014-09-29 | 2014-12-16 | 오스템임플란트 주식회사 | 시술 편의성이 향상된 치과용 치은확장기 |
Also Published As
Publication number | Publication date |
---|---|
KR20190081534A (ko) | 2019-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2576422C (en) | Anti-adhesion barrier | |
Liu et al. | A highly-stretchable and adhesive hydrogel for noninvasive joint wound closure driven by hydrogen bonds | |
JP5800821B2 (ja) | 組織拡張器 | |
EP0773034A1 (en) | Biodegradable in-situ forming implants | |
EP2427226B1 (en) | Implant filling material and method | |
DE69737909D1 (de) | Polymerisierbare biologisch abbaubare polymere mit carbonat-oder dioxanonbindungen | |
JP2018122111A (ja) | 選択的重合性組成物およびin vivoでのその使用方法 | |
US20040105880A1 (en) | Interpenetrating polymer network | |
WO2019132536A1 (ko) | 생분해성 물질을 포함하는 팽창 속도가 제어된 치과용 기구 및 이의 제조 방법 | |
EP0153407A1 (en) | INJECTABLE PHYSIOLOGICALLY SAFE POLYMER COMPOSITIONS. | |
KR101303284B1 (ko) | 히알루론산과 콘드로이틴 설페이트를 함유한 수화겔 및 이의 제조방법 | |
EP3305339B1 (en) | Method for manufacturing collagen film using ultraviolet light, collagen film manufactured by using same, and biomaterial prepared using collagen film | |
KR200475611Y1 (ko) | 시술 편의성이 향상된 치과용 치은확장기 | |
KR101668679B1 (ko) | 시술 편의성이 높은 치과용 치은 확장기의 제조 방법 및 이러한 방법으로 제조된 치은 확장기 | |
Fisher et al. | Multifunctional poly (β-amino ester) hydrogel microparticles in periodontal in situ forming drug delivery systems | |
Majkus et al. | Employment of hydron polymer antibiotic vehicle in otolaryngology | |
KR102259646B1 (ko) | 팽창 속도가 조절되는 치은 확장기 및 이의 제조 방법 | |
EP2638922B1 (en) | Multi-components adhesives, manufacturing thereof, and applications thereof | |
KR20080066980A (ko) | 공막돌륭술 밴드 및 이의 제조 방법 | |
Gharat et al. | Compressive review on hydrogel | |
CN113144275A (zh) | 一种水凝胶粘合剂及其制备方法和应用 | |
KR20190050025A (ko) | 치과용 티슈 확장기 및 이의 제조방법 | |
US8084513B2 (en) | Implant filling material and method | |
KR102143356B1 (ko) | 변성 하이드로젤 및 이를 포함하는 치은 확장기 | |
Mohan et al. | An Insight into Hydrogel Drug Delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18897351 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18897351 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 21/01/2021) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18897351 Country of ref document: EP Kind code of ref document: A1 |